Cost-effectiveness of treating all hepatitis B-positive individuals in the United States. Razavi-Shearer D, Estes C, Gamkrelidze I, Razavi H, et al. J Viral Hepat 2023 Jun 1. doi: 10.1111/jvh.13843.

Read + Share

Amedeo Smart

Independent Medical Education

Razavi-Shearer D, Estes C, Gamkrelidze I, Razavi H, et al. Cost-effectiveness of treating all hepatitis B-positive individuals in the United States. J Viral Hepat 2023 Jun 1. doi: 10.1111/jvh.13843.
PMID: 37260095